AbCellera Biologics Inc. (ABCL) Social Stream



AbCellera Biologics Inc. (ABCL): $3.12

0.01 (-0.32%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add ABCL to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#297 of 341

in industry

ABCELLERA BIOLOGICS INC (ABCL) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ABCL.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 5 $53 $25 $42.75 $5.71 648.69%
2021-12-05 5 $53 $25 $40.8 $5.71 614.54%
2021-12-19 7 $53 $25 $39.833 $5.71 597.6%
2021-12-21 7 $53 $25 $38 $5.71 565.5%
2022-02-11 5 $45 $25 $33 $5.71 477.93%
2022-02-25 5 $40 $20 $30 $5.71 425.39%
2022-05-09 5 $40 $20 $29.6 $5.71 418.39%
2022-05-11 5 $32 $14 $24.8 $5.71 334.33%
2022-08-09 5 $32 $14 $23.6 $5.71 313.31%
2022-08-11 5 $34 $14 $24 $5.71 320.32%
2022-10-23 5 $34 $13 $23.8 $5.71 316.81%
2022-11-02 4 $34 $13 $23.6 $5.71 313.31%
2022-11-09 5 $32 $20 $23.6 $5.71 313.31%
2022-11-30 6 $32 $20 $24.5 $5.71 329.07%
2022-12-15 6 $32 $20 $25.285 $5.71 342.82%
2023-01-06 6 $32 $18 $25 $5.71 337.83%
2023-02-21 7 $32 $18 $25 $5.71 337.83%
2023-02-22 7 $32 $18 $26.142 $5.71 357.83%
2023-04-20 7 $32 $16 $26.833 $5.71 369.93%
2023-05-04 7 $32 $15 $25.833 $5.71 352.42%
2023-05-11 7 $32 $15 $25.666 $5.71 349.49%
2023-05-26 7 $31 $15 $25 $5.71 337.83%
2023-08-03 7 $32.001 $15 $26.166 $5.71 358.25%
2023-08-07 7 $32.001 $13 $25.833 $5.71 352.42%
2023-08-31 8 $32 $12 $23 $5.71 302.8%
2023-11-02 9 $32 $12 $22.625 $5.71 296.23%
2023-11-03 10 $32 $10 $20.75 $5.71 263.4%
2023-12-05 10 $32 $6 $19.111 $5.71 234.69%

The Trend in the Analyst Price Target


Over the past 41 weeks, ABCL's average price target has gone down $5.89.

Over the past 41 weeks, ABCL's average upside potential has been 288.48%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-22 7 32.000 18 26.142 8.79 197.41%
2023-07-21 7 32.001 15 26.166 7.85 233.32%
2023-08-07 7 32.001 13 24.833 5.85 324.5%
2023-11-02 9 32.000 12 22.625 4.43 410.72%
2023-11-03 9 32.000 10 20.750 4.70 341.49%

ABCL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.2 9 0 1 0 0 10

The Trend in the Broker Recommendations


ABCL's average broker recommendation rating worsened by 0.2 over the prior 31 weeks.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, ABCELLERA BIOLOGICS INC's upside potential (average analyst target price relative to current price) is higher than 3967.76% of them.
  • ABCELLERA BIOLOGICS INC's number of analysts covering the stock is higher than 396.03% of stocks in the large market cap category.
  • In terms of how ABCELLERA BIOLOGICS INC fares relative to stocks in the large market cap category, note that its average analyst price target is greater than 679.28% of that group.
  • In terms of how ABCELLERA BIOLOGICS INC fares relative to stocks in the large market cap category, note that its variance in analysts' estimates is lower than -3160.83% of that group.

In the Pharmaceutical Products industry, BLUE, NTLA, and APLS are the three stocks most similar to ABCELLERA BIOLOGICS INC regarding the price target and analyst recommendation information presented here.

Is ABCL a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!